Since the first description of a coronavirus-related pneumonia outbreak in December 2019,
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …

Summary As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive
care unit (ICU) community must prepare for the challenges associated with this pandemic …

Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19
has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased …

Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …

Objective To investigate the occurrence of olfactory and gustatory dysfunctions in patients
with laboratory-confirmed COVID-19 infection. Methods Patients with laboratory-confirmed …

Without modern medical management and vaccines, the severity of the Coronavirus
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …

Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …

Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
virus that caused coronavirus disease 2019 (COVID-19), the use of face masks has become …

As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has been responsible for 379,661 infection cases with 16,428 deaths globally, and the …